CymaBay announces retirement of President and CEO, Harold Van Wart, Ph.D.
CymaBay Therapeutics announced that Harold Van Wart, PhD, will retire as President and CEO. The Board of Directors has promoted Sujal Shah, to interim President and CEO. During this transition Robert Wills, PhD, will assume the role of Executive Chairman to provide additional continuity and support. March 29, 2017